The democratization of AI takes on added significance with the advent of generative AI facilitating human genome editing. Ali Madani, Founder and CEO of Biotechnology company Profluent, announced a groundbreaking…

University of Cambridge scientists have employed artificial intelligence (AI) to expedite the quest for novel Parkinson’s disease therapies. Through machine learning techniques, they efficiently screened millions of potential drug compounds,…